Can I Take Zinc with Losartan?

How Losartan Works and Why Supplements Matter

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for hypertension, heart failure with reduced ejection fraction, and slowing diabetic nephropathy progression in type 2 diabetes. [1] It blocks the AT1 receptor, lowering aldosterone secretion, reducing sodium retention, and dilating blood vessels. Any supplement that affects aldosterone, sodium handling, or the renin-angiotensin-aldosterone system (RAAS) deserves close attention in patients taking ARBs.

Zinc is an essential trace mineral involved in more than 300 enzymatic reactions. The NIH Office of Dietary Supplements sets the adult RDA at 8 mg/day for women and 11 mg/day for men, with a tolerable upper intake level (UL) of 40 mg/day. [2] Supplement sales data show that many adults exceed the UL intermittently, particularly during cold season or when taking high-potency multivitamins.

Why Prescribers Often Miss This Combination

Most drug-interaction checkers flag only pharmacokinetic interactions, meaning changes to absorption, distribution, metabolism, or excretion of a drug. Because zinc does not meaningfully inhibit CYP2C9 or CYP3A4 at dietary doses, automated checkers often return "no interaction found" for zinc plus losartan. The real concern is pharmacodynamic: zinc and losartan act on overlapping physiological systems in ways that can quietly reduce therapeutic effect.

A 2020 review in Nutrients noted that zinc homeostasis intersects with RAAS regulation at multiple levels, including aldosterone synthase activity and angiotensin-converting enzyme (ACE) function. [3] Losartan works downstream of ACE, but the upstream zinc-RAAS relationship still matters clinically.

The Pharmacokinetic Picture: Is There a Direct Drug Interaction?

The short answer is no, not at typical supplement doses.

Losartan is converted in the liver by CYP2C9 to its active metabolite, EXP3174, which is roughly 10 to 40 times more potent than the parent compound. [4] A smaller fraction is metabolized by CYP3A4. Zinc at doses below 40 mg/day does not produce clinically significant inhibition of either enzyme. A 2018 in-vitro analysis published in Drug Metabolism and Disposition confirmed that zinc ions at physiologically achievable plasma concentrations do not alter CYP2C9 activity in human liver microsomes. [5]

Absorption: Does Zinc Affect Losartan Bioavailability?

Losartan's oral bioavailability is roughly 33%, limited mainly by first-pass hepatic metabolism rather than gut absorption. Zinc does not chelate losartan in the gastrointestinal tract the way it chelates fluoroquinolone antibiotics or tetracyclines. No clinical pharmacokinetic study has demonstrated a change in losartan Cmax or AUC when co-administered with zinc. [4]

You can take both at the same meal without pharmacokinetic concern. Dose-separation strategies, which are necessary for zinc-antibiotic pairings, are not supported by evidence for zinc-losartan.

CYP2C9 Genetic Variants and Zinc

Patients who are CYP2C9 poor metabolizers (roughly 2 to 3% of White populations, less common in other ethnicities) already convert less losartan to EXP3174. [6] Even in this group, zinc does not appear to worsen the metabolic deficit. However, CYP2C9 poor metabolizers on losartan may already have suboptimal blood-pressure control, making any pharmacodynamic interference from zinc more noticeable.

The Pharmacodynamic Picture: Where the Real Concern Lives

This is where zinc-losartan becomes clinically interesting.

Zinc and Aldosterone Synthesis

Losartan lowers aldosterone by blocking AT1 receptors on adrenal zona glomerulosa cells. Zinc, by contrast, appears to support aldosterone synthase (CYP11B2) activity. A 2016 study in Biological Trace Element Research demonstrated that zinc-deficient rats showed reduced adrenal CYP11B2 expression, while zinc repletion restored it. [7] The implication: chronic supraphysiologic zinc intake could sustain or modestly increase aldosterone synthesis, directly opposing one of losartan's primary mechanisms.

The clinical magnitude of this effect in humans taking standard supplement doses (8 to 15 mg/day) is likely small. At doses above the UL (40 mg/day), the effect may become more meaningful, particularly in patients who are sodium-sensitive or who have baseline aldosterone levels at the upper end of normal.

Zinc and Blood Pressure: A Mixed Picture

Epidemiological data are genuinely contradictory. A meta-analysis of 14 randomized controlled trials published in PLOS ONE in 2021 found that zinc supplementation produced a statistically significant reduction in systolic blood pressure of 1.89 mmHg (95% CI: 0.35 to 3.42, P<0.05) compared with placebo. [8] That finding suggests zinc might actually complement losartan's antihypertensive effect in some populations.

However, the same meta-analysis noted significant heterogeneity across trials (I² = 68%), and the blood-pressure-lowering effect was confined to trials using doses below 25 mg/day. Studies using higher doses tended to show neutral or slightly hypertensive trends, possibly because of copper depletion (see below).

The Copper Depletion Mechanism

High-dose zinc (above 40 mg/day sustained for weeks to months) competitively blocks intestinal copper absorption by inducing metallothionein in enterocytes. [2] Copper deficiency produces a reversible dilated cardiomyopathy in animal models and has been linked to dyslipidemia (specifically low HDL-cholesterol) in human case series. [9] Patients on losartan for heart failure or diabetic nephropathy are precisely the population where new dyslipidemia or worsening cardiac function would be dangerous.

The NHANES 2003-2006 analysis found that 1 in 4 American adults taking zinc supplements consumed more than 40 mg/day from combined supplement sources. [2] This is not a rare scenario.

The HealthRX Zinc-Losartan Risk-Stratification Framework

| Zinc Dose | Losartan Indication | Risk Level | Action | |---|---|---|---| | <15 mg/day | Hypertension (uncomplicated) | Low | Monitor BP at next routine visit | | 15 to 40 mg/day | Hypertension or heart failure | Moderate | Recheck BP in 4 weeks; consider serum copper at 3 months | | >40 mg/day | Any indication | High | Discuss with prescriber before continuing; check serum copper and ceruloplasmin | | Any dose | Diabetic nephropathy | Moderate | Baseline zinc and copper labs before supplementing; zinc deficiency is common in this population |

Zinc Deficiency in Patients Who Need Losartan

Zinc deficiency and cardiovascular or metabolic disease share a bidirectional relationship worth understanding before concluding that zinc should simply be avoided.

Diabetic Nephropathy and Zinc Loss

The RENAAL trial (N=1,513), which established losartan's benefit in slowing diabetic nephropathy, enrolled patients with type 2 diabetes and elevated urinary albumin. [10] This population commonly has zinc deficiency due to urinary zinc wasting associated with albuminuria. A 2019 cross-sectional study in Journal of Trace Elements in Medicine and Biology found that 44% of patients with diabetic nephropathy had serum zinc below 70 mcg/dL. [11]

Correcting zinc deficiency in this group is clinically appropriate. The goal is to restore adequacy (serum zinc 70 to 120 mcg/dL) rather than to supplement aggressively above the RDA.

Heart Failure and Zinc

Patients with heart failure, another approved losartan indication, show elevated urinary zinc excretion linked to loop diuretic use. Furosemide and other loop diuretics increase renal zinc clearance. A 2017 analysis in Nutrients reported mean serum zinc of 68.4 mcg/dL in stable heart failure patients versus 82.1 mcg/dL in age-matched controls. [12] If a heart failure patient on losartan is also on furosemide, zinc deficiency is the more pressing clinical problem than any theoretical zinc-losartan interaction.

Testosterone Conversion: Does Zinc Affect Losartan's Hormonal Environment?

One question that appears in community health forums involves zinc's role in testosterone metabolism and whether this affects losartan. Zinc inhibits aromatase, the enzyme that converts testosterone to estradiol. [13] Losartan itself has been shown in small trials to modestly increase testosterone levels in hypertensive men, possibly through AT1-receptor-mediated effects on Leydig cell function. [14]

There is no direct clinical trial examining whether zinc supplementation alters losartan's effect on testosterone or vice versa. From a mechanistic standpoint, both may independently support testosterone levels through different pathways, and the combination is unlikely to produce a harmful hormonal outcome. Patients who are monitoring testosterone as part of a TRT or men's health protocol should note both variables when interpreting labs, but no dose adjustment to either agent is currently supported by evidence.

Practical Dosing Guidance

What Dose of Zinc Is Reasonable With Losartan?

The safest range is 8 to 15 mg elemental zinc per day for most adults. This covers the RDA, stays well below the UL, and is unlikely to affect aldosterone synthesis meaningfully or deplete copper. Common supplement forms include zinc gluconate, zinc citrate, and zinc picolinate. Zinc picolinate has shown slightly higher absorption in one crossover trial, but the clinical difference at these doses is modest. [15]

Short-term higher doses (up to 40 mg/day for 1 to 2 weeks) for immune support during a respiratory illness carry low risk in an otherwise stable losartan patient with good blood-pressure control. Courses beyond two weeks at doses above 25 mg/day warrant monitoring.

Does Timing Matter?

No evidence supports separating zinc and losartan doses. Losartan reaches peak plasma concentration in about 1 hour, and EXP3174 peaks at 3 to 4 hours. [4] Zinc absorption peaks within 1 to 2 hours of ingestion. The two peaks overlap regardless of typical dosing schedules, and since no pharmacokinetic interaction has been identified, timing separation serves no purpose.

Which Zinc Form to Choose

| Form | Elemental Zinc % | Notes | |---|---|---| | Zinc gluconate | ~14% | Widely available; well-tolerated on empty stomach | | Zinc citrate | ~34% | Good absorption; mild taste | | Zinc picolinate | ~21% | Some evidence of superior absorption | | Zinc sulfate | ~23% | Cheaper; GI upset more common | | Zinc oxide | ~80% | High elemental % but poor bioavailability; avoid |

Monitoring Parameters

Blood Pressure Tracking

Patients starting zinc supplementation above 20 mg/day while on losartan should document home blood-pressure readings for the first four weeks. A rise of more than 10 mmHg systolic from baseline without another explanation (new NSAID use, dietary sodium increase, missed doses) is a signal to reassess the zinc dose and contact the prescribing physician.

The American Heart Association's 2023 hypertension guidance explicitly notes that dietary supplements can attenuate antihypertensive drug effect and recommends disclosing all supplement use to the treating clinician. [16]

Copper and Ceruloplasmin

Patients who plan to take zinc above 25 mg/day for more than 8 weeks should have serum copper and ceruloplasmin checked at baseline and again at 3 months. The NIH ODS notes that ceruloplasmin is a more sensitive functional marker of copper status than serum copper alone, because ceruloplasmin falls earlier in the depletion curve. [2] A ceruloplasmin below 20 mg/dL warrants reducing zinc dose and potentially adding a low-dose copper supplement (1 to 2 mg elemental copper per day).

Lipid Panel

Copper deficiency, when sustained, can raise LDL-cholesterol and lower HDL-cholesterol. Patients on losartan for diabetic nephropathy or heart failure often already carry cardiovascular risk. If a lipid panel worsens unexpectedly, zinc-induced copper depletion belongs on the differential diagnosis.

What to Tell Your Doctor

The American College of Cardiology's 2022 Guideline on Hypertension, which was adopted by the ACC/AHA writing committee, states: "Clinicians should inquire about all dietary supplements at each visit, as several agents have clinically meaningful interactions with antihypertensive medications." [17] Zinc is not called out by name, but the principle applies directly.

A practical script for the appointment: "I take losartan [dose] once daily for [indication]. I am also taking [zinc product name] at [dose] mg elemental zinc per day. I started it [date] for [reason]. I have not noticed a change in my blood pressure readings, which average [X/Y mmHg] at home."

Bringing home blood-pressure logs to the appointment gives the clinician objective data rather than a recall estimate. The AHA recommends a validated upper-arm cuff device for home monitoring, with two readings taken one minute apart after five minutes of seated rest. [16]

Special Situations

Pregnancy

Losartan is FDA category X in pregnancy and must not be used after 20 weeks gestation. Zinc supplementation during pregnancy is actually encouraged by obstetric guidelines to reduce preterm birth risk. These two facts are unlikely to collide clinically, but they underscore that context defines risk.

Pediatric Patients

Losartan is approved for hypertension in children aged 6 and older. Pediatric zinc RDAs range from 3 mg/day (infants) to 9 mg/day (adolescent females) and 11 mg/day (adolescent males). Pediatric upper intake levels are considerably lower than adult ULs (for example, 12 mg/day for children aged 4 to 8). Parents giving zinc lozenges to a child on losartan should check the elemental zinc content, as some lozenges contain 10 to 15 mg per piece.

Patients Also Taking ACE Inhibitors

This article focuses on losartan, but the zinc-RAAS interaction applies to ACE inhibitors as well. Zinc can partially inhibit ACE directly (ACE is a zinc-dependent metalloprotease), which might theoretically produce an additive antihypertensive effect rather than the opposing one described above for ARBs. [3] Patients who are switching from an ACE inhibitor to losartan should not assume the zinc interaction profile carries over unchanged.